These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12116023)

  • 1. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
    Wang HF; Li L; Su HB; Ji W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
    Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
    Lau GK; Tsiang M; Hou J; Yuen S; Carman WF; Zhang L; Gibbs CS; Lam S
    Hepatology; 2000 Aug; 32(2):394-9. PubMed ID: 10915748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
    Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
    Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
    Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
    Hultgren C; Weiland O; Milich DR; Sällberg M
    Clin Infect Dis; 1999 Dec; 29(6):1575-7. PubMed ID: 10585820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].
    Wang ZY; Guo SH; Zhang DF; Zhao YR; Ren H; Zhou XQ; Xu DZ; Sun JY; Yao JL; Lu WL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):494-6. PubMed ID: 16042882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Famciclovir treatment of patients with chronic hepatitis B virus infection].
    Li L; Shao Q; Zhang J; Ji D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):390-1. PubMed ID: 12665916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B.
    de Man RA; Marcellin P; Habal F; Desmond P; Wright T; Rose T; Jurewicz R; Young C
    Hepatology; 2000 Aug; 32(2):413-7. PubMed ID: 10915751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
    Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
    J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different treatment combinations for chronic hepatitis B infection.
    Demirtürk N; Usluer G; Ozgünes I; Colak H; Kartal ED; Dinçer S
    J Chemother; 2002 Jun; 14(3):285-9. PubMed ID: 12120884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telbivudine versus lamivudine in patients with chronic hepatitis B.
    Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
    N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
    Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
    N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic changes of hepatitis B virus during treatment with lamivudine versus lamivudine plus famciclovir].
    Hou J; Fen X; Nie Z
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):81-3. PubMed ID: 10861109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].
    Lu WL; Xie DY; Yao JL; Yao GB; Cui ZY; Zhang DF; Wu L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):429-31. PubMed ID: 15268810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
    Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
    J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.